. 2017 Jan:81:101-110.

doi: 10.1016/j.jclinepi.2016.09.009. Epub 2016 Oct 3.

GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT

Holger J Schünemann¹, Wojtek Wiercioch², Jan Brozek³, Itziar Etxeandia-Ikobaltzeta², Reem A Mustafa⁴, Veena Manja⁵, Romina Brignardello-Petersen⁶, Ignacio Neumann⁷, Maicon Falavigna⁸, Waleed Alhazzani³, Nancy Santesso², Yuan Zhang², Jörg J Meerpohl⁹, Rebecca L Morgan², Bram Rochwerg², Andrea Darzi¹⁰, Maria Ximenas Rojas¹¹, Alonso Carrasco-Labra⁷, Yaser Adi¹², Zulfa AlRayees¹³, John Riva¹⁴, Claudia Bollig¹⁵, Ainsley Moore¹⁴, Juan José Yepes-Nuñez², Carlos Cuello¹⁶, Reem Waziry¹⁷, Elie A Akl¹⁸

Affiliations

¹ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada. Electronic address: schuneh@mcmaster.ca.
² Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada.
³ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada.
⁴ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Internal Medicine/Nephrology, University of Missouri-Kansas City, 2301 Holmes Street, Kansas City, MO 64108, USA; Department of Biomedical and Health Informatics, University of Missouri-Kansas City, 2411 Holmes Street, Kansas City, MO 64108, USA.
⁵ Division of Cardiology, Department of Medicine, Veterans Affairs Medical Center, 3495 Bailey Avenue, Buffalo, NY 14215, USA; Department of Internal Medicine, University at Buffalo, The State University of New York, 3435 Main street, Buffalo, NY 14214, USA.
⁶ Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College St, Toronto, ON M5T 3M6, Canada; Evidence-Based Dentistry Unit, Faculty of Dentistry, Universidad de Chile, Sergio Livingstone Pohlhammer 943, Independencia, Santiago 8380492, Chile.
⁷ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Internal Medicine, Pontificia Universidad Católica de Chile, Alameda 340, Santiago 8331150, Chile.
⁸ Hospital Moinhos de Vento, Rua Ramiro Barcelos 910, Bairro Moinhos de Vento, Porto Alegre, Brazil; National Institute of Science and Technology for Health Technology Assessment, Federal University of Rio Grande do Sul, Rua Ramiro Barcelos, No. 2359, 90035-903 Porto Alegre, RS, Brazil.
⁹ Cochrane Germany, Medical Center-University of Freiburg, Breisacher Strasse 153, Freiburg 79110, Germany; Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité-U1153, Inserm/Université Paris Descartes, Cochrane France, Hôpital Hôtel-Dieu, 1 place du Parvis Notre Dame, 75181 Paris Cedex 04, France.
¹⁰ Department of Biomedical and Health Informatics, University of Missouri-Kansas City, 2411 Holmes Street, Kansas City, MO 64108, USA.
¹¹ Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Hospital Universitario de San Ignacio, Cr. 7 40-62 2nd Floor, Bogotá, Colombia.
¹² King Faisal Specialist Hospital and Research Centre, Zahrawi Street, Al Maather, P.O. Box 3354 Riyadh 11211, Saudi Arabia.
¹³ Saudi Centre for Evidence Based Health Care, Ministry of Health, King Abdulaziz Road, Riyadh 11176, Saudi Arabia.
¹⁴ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Family Medicine, McMaster University, David Braley Health Sciences Centre, 100 Main Street West, 6th Floor, Hamilton, Ontario L8P 1H6, Canada.
¹⁵ Cochrane Germany, Medical Center-University of Freiburg, Breisacher Strasse 153, Freiburg 79110, Germany.
¹⁶ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Tecnologico de Monterrey School of Medicine, Avda. Morones Prieto 3000 pte. CP 64710 Monterrey, Nuevo León, Mexico.
¹⁷ Department of Internal Medicine, Faculty of Health Sciences, American University of Beirut, P.O. Box: 11-0236, Riad-El-Solh Beirut 1107 2020, Beirut, Lebanon; The Kirby Institute, University of New South Wales, Wallace Wurth Building, University of New South Wales, Sydney, New South Wales 2052, Australia.
¹⁸ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Internal Medicine, Faculty of Health Sciences, American University of Beirut, P.O. Box: 11-0236, Riad-El-Solh Beirut 1107 2020, Beirut, Lebanon.

PMID: 27713072
DOI: 10.1016/j.jclinepi.2016.09.009

Free article

GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT

Holger J Schünemann et al. J Clin Epidemiol. 2017 Jan.

Free article

. 2017 Jan:81:101-110.

doi: 10.1016/j.jclinepi.2016.09.009. Epub 2016 Oct 3.

Authors

Affiliations

¹ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada. Electronic address: schuneh@mcmaster.ca.
² Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada.
³ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada.
⁴ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Internal Medicine/Nephrology, University of Missouri-Kansas City, 2301 Holmes Street, Kansas City, MO 64108, USA; Department of Biomedical and Health Informatics, University of Missouri-Kansas City, 2411 Holmes Street, Kansas City, MO 64108, USA.
⁵ Division of Cardiology, Department of Medicine, Veterans Affairs Medical Center, 3495 Bailey Avenue, Buffalo, NY 14215, USA; Department of Internal Medicine, University at Buffalo, The State University of New York, 3435 Main street, Buffalo, NY 14214, USA.
⁶ Institute of Health Policy, Management and Evaluation, University of Toronto, 155 College St, Toronto, ON M5T 3M6, Canada; Evidence-Based Dentistry Unit, Faculty of Dentistry, Universidad de Chile, Sergio Livingstone Pohlhammer 943, Independencia, Santiago 8380492, Chile.
⁷ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Internal Medicine, Pontificia Universidad Católica de Chile, Alameda 340, Santiago 8331150, Chile.
⁸ Hospital Moinhos de Vento, Rua Ramiro Barcelos 910, Bairro Moinhos de Vento, Porto Alegre, Brazil; National Institute of Science and Technology for Health Technology Assessment, Federal University of Rio Grande do Sul, Rua Ramiro Barcelos, No. 2359, 90035-903 Porto Alegre, RS, Brazil.
⁹ Cochrane Germany, Medical Center-University of Freiburg, Breisacher Strasse 153, Freiburg 79110, Germany; Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité-U1153, Inserm/Université Paris Descartes, Cochrane France, Hôpital Hôtel-Dieu, 1 place du Parvis Notre Dame, 75181 Paris Cedex 04, France.
¹⁰ Department of Biomedical and Health Informatics, University of Missouri-Kansas City, 2411 Holmes Street, Kansas City, MO 64108, USA.
¹¹ Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Hospital Universitario de San Ignacio, Cr. 7 40-62 2nd Floor, Bogotá, Colombia.
¹² King Faisal Specialist Hospital and Research Centre, Zahrawi Street, Al Maather, P.O. Box 3354 Riyadh 11211, Saudi Arabia.
¹³ Saudi Centre for Evidence Based Health Care, Ministry of Health, King Abdulaziz Road, Riyadh 11176, Saudi Arabia.
¹⁴ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Family Medicine, McMaster University, David Braley Health Sciences Centre, 100 Main Street West, 6th Floor, Hamilton, Ontario L8P 1H6, Canada.
¹⁵ Cochrane Germany, Medical Center-University of Freiburg, Breisacher Strasse 153, Freiburg 79110, Germany.
¹⁶ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Tecnologico de Monterrey School of Medicine, Avda. Morones Prieto 3000 pte. CP 64710 Monterrey, Nuevo León, Mexico.
¹⁷ Department of Internal Medicine, Faculty of Health Sciences, American University of Beirut, P.O. Box: 11-0236, Riad-El-Solh Beirut 1107 2020, Beirut, Lebanon; The Kirby Institute, University of New South Wales, Wallace Wurth Building, University of New South Wales, Sydney, New South Wales 2052, Australia.
¹⁸ Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario L8N 4K1, Canada; Department of Internal Medicine, Faculty of Health Sciences, American University of Beirut, P.O. Box: 11-0236, Riad-El-Solh Beirut 1107 2020, Beirut, Lebanon.

PMID: 27713072
DOI: 10.1016/j.jclinepi.2016.09.009

Abstract

Background: Guideline developers can: (1) adopt existing recommendations from others; (2) adapt existing recommendations to their own context; or (3) create recommendations de novo. Monetary and nonmonetary resources, credibility, maximization of uptake, as well as logical arguments should guide the choice of the approach and processes.

Objectives: To describe a potentially efficient model for guideline production based on adoption, adaptation, and/or de novo development of recommendations utilizing the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks.

Study design and setting: We applied the model in a new national guideline program producing 22 practice guidelines. We searched for relevant evidence that informs the direction and strength of a recommendation. We then produced GRADE EtDs for guideline panels to develop recommendations.

Results: We produced a total of 80 EtD frameworks in approximately 4 months and 146 EtDs in approximately 6 months in two waves. Use of the EtD frameworks allowed panel members understand judgments of others about the criteria that bear on guideline recommendations and then make their own judgments about those criteria in a systematic approach.

Conclusion: The "GRADE-ADOLOPMENT" approach to guideline production combines adoption, adaptation, and, as needed, de novo development of recommendations. If developers of guidelines follow EtD criteria more widely and make their work publically available, this approach should prove even more useful.

Keywords: Adaptation; Clinical practice guidelines; Evidence to Decision framework; Evidence-based medicine; GRADE; Recommendation.

PubMed Disclaimer

Cited by

2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea.
Kim BY, Kang SM, Kang JH, Kang SY, Kim KK, Kim KB, Kim B, Kim SJ, Kim YH, Kim JH, Kim JH, Kim EM, Nam GE, Park JY, Son JW, Shin YA, Shin HJ, Oh TJ, Lee H, Jeon EJ, Chung S, Hong YH, Kim CH; Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO). Kim BY, et al. J Obes Metab Syndr. 2021 Jun 30;30(2):81-92. doi: 10.7570/jomes21022. J Obes Metab Syndr. 2021. PMID: 34045368 Free PMC article. Review.
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.
Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E. Brandow AM, et al. Blood Adv. 2020 Jun 23;4(12):2656-2701. doi: 10.1182/bloodadvances.2020001851. Blood Adv. 2020. PMID: 32559294 Free PMC article.
Adolopment of adult diabetes mellitus management guidelines for a Pakistani context: Methodology and challenges.
Martins RS, Masood MQ, Mahmud O, Rizvi NA, Sheikh A, Islam N, Khowaja ANA, Ram N, Furqan S, Mustafa MA, Aamdani SS, Pervez A, Haider AH, Nadeem S. Martins RS, et al. Front Endocrinol (Lausanne). 2023 Jan 5;13:1081361. doi: 10.3389/fendo.2022.1081361. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686436 Free PMC article.
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.
Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J, Balduzzi S, Darzi A, Morgano GP, Neumann I, Nieuwlaat R, Yepes-Nuñez JJ, Zhang Y, Wiercioch W. Schünemann HJ, et al. Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954. Blood Adv. 2018. PMID: 30482763 Free PMC article.
Evidence-based pharmacological prophylaxis recommendations for venous thromboembolism in hospitalized acutely ill medical patients: a systematic review of clinical practice guidelines.
de Souza APC, Gabriel FC, Fontes-Mota GCH, Silva MS, Ribeiro E. de Souza APC, et al. J Vasc Bras. 2023 Aug 7;22:e20230067. doi: 10.1590/1677-5449.202300672. eCollection 2023. J Vasc Bras. 2023. PMID: 37576726 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT

Affiliations

GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources